BIOTECHNOLOGY RES CORP LTD has a total of 20 patent applications. Its first patent ever was published in 2007. It filed its patents most often in China, United Kingdom and Hong Kong. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are NEUROTUNE AG, MINOFUAAGEN SEIYAKU KK and CLAVIS PHARMA ASA.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 5 | |
#2 | United Kingdom | 5 | |
#3 | Hong Kong | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Hu Yueqing | 10 |
#2 | Ip Fanny Chui Fun | 8 |
#3 | Ip Nancy Yuk-Yu | 8 |
#4 | Ip Nancy Y | 6 |
#5 | Ip Fanny Chui-Fun | 5 |
#6 | Wu Zhenguo | 4 |
#7 | Fu Kit Yu | 4 |
#8 | Chung Sookja Kim | 4 |
#9 | Ye Wen Cai | 4 |
#10 | Han Yifan | 4 |
Publication | Filing date | Title |
---|---|---|
HK1153203A1 | Triterpenoid compounds and methods of use thereof | |
CN102946877A | Neuro-protective effects of adelostemma gracillimum and its isolated compounds | |
CN102164942A | Triterpenoid compounds and methods of use thereof | |
GB201011914D0 | Oxazolidine derivatives as NMDA antagonists | |
CN102112879A | STAT3 and TYK2 as drug targets for neurodegenerative diseases | |
GB0920516D0 | Receptor modulators exhibiting neuroprotective andmemory enhancing activities | |
US2008176308A1 | Heterodimers and methods of using them |